Clinical Microbiology Newsletter
Volume 30, Issue 8 , Pages 55-62 , 15 April 2008

Staphylococcus lugdunensis — Not the Average Coagulase-Negative Staphylococcus Species

  • Kristi L. Frank, Ph.D.

      Affiliations

    • Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota
    • ,
  • Robin Patel, M.D.

      Affiliations

    • Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Corresponding Author InformationMailing Address: Robin Patel, M.D., Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First St. S.W., Rochester, MN 55905. Tel.: 507-538-0579. Fax: 507-284-4272.

References 

  1. Freney J , et al.   Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens . Int. J. Syst. Bacteriol. . 1988;38:168–172
  2. Becker K , et al.   Does nasal cocolonization by methicillin-resistant coagulase-negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods? . J. Clin. Microbiol. . 2006;44:229–231
  3. Koziol-Montewka M , et al.   The investigation of Staphylococcus aureus and coagulase-negative staphylococci nasal carriage among patients undergoing haemodialysis . Microbiol. Res. . 2006;161:281–287
  4. van der Mee-Marquet N , et al.   Staphylococcus lugdunensis infections: high frequency of inguinal area carriage . J. Clin. Microbiol. . 2003;41:1404–1409
  5. Frank KL , del Pozo JL , Patel R . From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. . Clin. Microbiol. Rev. . 2008;21:111–133
  6. Herchline TE , Ayers LW . Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection . J. Clin. Microbiol. . 1991;29:419–421
  7. Kawamura Y , et al.   Distribution of Staphylococcus species among human clinical specimens and emended description of Staphylococcus caprae . J. Clin. Microbiol. . 1998;36:2038–2042
  8. Akiyama H , et al.   Coagulase-negative staphylococci isolated from various skin lesions . J. Dermatol. . 1998;25:563–568
  9. Asnis DS , et al.   Staphylococcus lugdunensis breast abscess: is it real? . Clin. Infect. Dis. . 2003;36:1348
  10. Tan TY , Ng SY , Ng WX . Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites . J. Clin. Microbiol. . 2006;44:3413–3414
  11. Etienne J , et al.   Staphylococcus lugdunensis endocarditis . Lancet . 1989;i:390
  12. Anguera I , et al.   Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles . Heart . 2005;91:e10
  13. Koh TW , Brecker SJ , Layton CA . Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: a case report and review of the literature . Int. J. Cardiol. . 1996;55:193–197
  14. Vandenesch F , et al.   Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review . Clin. Infect. Dis. . 1993;17:871–876
  15. Patel R , et al.   Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience . J. Clin. Microbiol. . 2000;38:4262–4263
  16. Trampuz A , et al.   Sonication of removed hip and knee prostheses for diagnosis of infection . N. Engl. J. Med. . 2007;357:654–663
  17. Sampathkumar P , Osmon DR , Cockerill FR . Prosthetic joint infection due to Staphylococcus lugdunensis . Mayo Clin. Proc. . 2000;75:511–512
  18. Camacho M , et al.   Three-year outcome in a patient with Staphylococcus lugdunensis discitis . Joint Bone Spine . 2002;69:85–87
  19. Greig JM , Wood MJ . Staphylococcus lugdunensis vertebral osteomyelitis . Clin. Microbiol. Infect. . 2003;9:1139–1141
  20. Murdoch DR , et al.   Vertebral osteomyelitis due to Staphylococcus lugdunensis . J. Clin. Microbiol. . 1996;34:993–994
  21. Weightman NC , Allerton KE , France J . Bone and prosthetic joint infection with Staphylococcus lugdunensis . J. Infect. . 2000;40:98–99
  22. Ebright JR , Penugonda N , Brown W . Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis . Diagn. Microbiol. Infect. Dis. . 2004;48:17–21
  23. Linehan D , et al.   Patterns of exoprotein production in isolates of Staphylococcus schleiferi and Staphylococcus lugdunensis . Biochem. Soc. Trans. . 1992;20:87S
  24. Pfaller MA , et al.   Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group . Diagn. Microbiol. Infect. Dis. . 1999;33:283–297
  25. Castro JG , Dowdy L . Septic shock caused by Staphylococcus lugdunensis . Clin. Infect. Dis. . 1999;28:681–682
  26. Fleurette J , et al.   Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents . Res. Microbiol. . 1989;140:107–118
  27. Pareja J , Gupta K , Koziel H . The toxic shock syndrome and Staphylococcus lugdunensis bacteremia . Ann. Intern. Med. . 1998;128:603–604
  28. Vandenesch F , et al.   Delta-like haemolysin produced by Staphylococcus lugdunensis . FEMS Microbiol. Lett. . 1991;62:65–68
  29. Vandenesch F , et al.   agr-related sequences in Staphylococcus lugdunensis . FEMS Microbiol. Lett. . 1993;111:115–122
  30. Novick RP . Autoinduction and signal transduction in the regulation of staphylococcal virulence . Mol. Microbiol. . 2003;48:1429–1449
  31. Donvito B , et al.   Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus . Infect. Immun. . 1997;65:95–100
  32. Donvito B , et al.   Distribution of the synergistic haemolysin genes hld and slush with respect to agr in human staphylococci . FEMS Microbiol. Lett. . 1997;151:139–144
  33. von Eiff C , Peters G , Heilmann C . Pathogenesis of infections due to coagulase-negative staphylococci . Lancet Infect. Dis. . 2002;2:677–685
  34. Lambe DW , et al.   Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors . Can. J. Microbiol. . 1990;36:455–463
  35. Ferguson KP , et al.   Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body . Can. J. Microbiol. . 1991;37:722–724
  36. Paulsson M , Petersson AC , Ljungh A . Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis . J. Med. Microbiol. . 1993;38:96–102
  37. Nilsson M , et al.   A von Willebrand factor-binding protein from Staphylococcus lugdunensis . FEMS Microbiol. Lett. . 2004;234:155–161
  38. Mitchell J , Tristan A , Foster TJ . Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis . Microbiology . 2004;150:3831–3841
  39. Nilsson M , et al.   A fibrinogen-binding protein of Staphylococcus lugdunensis . FEMS Microbiol. Lett. . 2004;241:87–93
  40. Frank KL , Patel R . Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates . Infect. Immun. . 2007;75:4728–4742
  41. Hébert GA . Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi . J. Clin. Microbiol. . 1990;28:2425–2431
  42. O'Gara JP . ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus . FEMS Microbiol. Lett. . 2007;270:179–188
  43. Gotz F . Staphylococcus and biofilms . Mol. Microbiol. . 2002;43:1367–1378
  44. Vuong C , et al.   A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence . J. Biol. Chem. . 2004;279:54881–54886
  45. Conlon KM , Humphreys H , O'Gara JP . icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis . J. Bacteriol. . 2002;184:4400–4408
  46. Chokr A , et al.   Correlation between biofilm formation and production of polysaccharide intercellular adhesin in clinical isolates of coagulase-negative staphylococci . Int. J. Med. Microbiol. . 2006;296:381–388
  47. Kogan G , et al.   Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin . FEMS Microbiol. Lett. . 2006;255:11–16
  48. Sadovskaya I , et al.   Carbohydrate-containing components of biofilms produced in vitro by some staphylococcal strains related to orthopaedic prosthesis infections . FEMS Immunol. Med. Microbiol. . 2006;47:75–82
  49. Kaplan JB , et al.   Enzymatic detachment of Staphylococcus epidermidis biofilms . Antimicrob. Agents Chemother. . 2004;48:2633–2636
  50. Frank KL , Patel R . Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci . Diagn. Microbiol. Infect. Dis. . 2007;60:9–16
  51. Bannerman TL , Peacock SJ . Staphylococcus, Micrococcus, and other catalase-positive cocci . In:  Murray PR , et al. editor. 9th ed.. Manual of clinical microbiology . vol. 1: Washington, DC: ASM Press; 2007;p. 390–411
  52. Etienne J , et al.   Plasmid profiles and genomic DNA restriction endonuclease patterns of 30 independent Staphylococcus lugdunensis strains . FEMS Microbiol. Lett. . 1990;55:93–97
  53. Poitevin-Later F , et al.   Cadmium-resistance plasmid in Staphylococcus lugdunensis . FEMS Microbiol. Lett. . 1992;78:59–63
  54. Hellbacher C , Tornqvist E , Soderquist B . Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates . Clin. Microbiol. Infect. . 2006;12:43–49
  55. Lina B , et al.   Comparison of coagulase-negative staphylococci by pulsed-field electrophoresis . FEMS Microbiol. Lett. . 1992;71:133–138
  56. Leung MJ , et al.   Colony variation in Staphylococcus lugdunensis . J. Clin. Microbiol. . 1998;36:3096–3098
  57. Seifert H , et al.   Staphylococcus lugdunensis pacemaker-related infection . Emerg. Infect. Dis. . 2005;11:1283–1286
  58. Frank KL , et al.   In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates . Antimicrob. Agents Chemother. . 2007;51:888–895
  59. Carroll KC , Weinstein MP . Manual and automated systems for detection and identification of microorganisms . In:  Murray PR , et al. editor. 9th ed. Manual of clinical microbiology . vol. 1: Washington, DC: ASM Press; 2007;p. 192–244
  60. Tee WS , et al.   Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate . J. Clin. Microbiol. . 2003;41:519–520
  61. Couto I , et al.   Identification of clinical staphylococcal isolates from humans by internal transcribed spacer PCR . J. Clin. Microbiol. . 2001;39:3099–3103
  62. Fujita S , et al.   Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis . J. Clin. Microbiol. . 2005;43:1149–1157
  63. Sivadon V , et al.   Use of genotypic identification by sodA sequencing in a prospective study to examine the distribution of coagulase-negative Staphylococcus species among strains recovered during septic orthopedic surgery and evaluate their significance . J. Clin. Microbiol. . 2005;43:2952–2954
  64. Kaabia N , et al.   Molecular identification of Staphylococcus lugdunensis in a patient with meningitis . J. Clin. Microbiol. . 2002;40:1824–1825
  65. Goldstein EJ , et al.   In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections . Antimicrob. Agents Chemother. . 2006;50:3959–3962
  66. Arciola CR , et al.   Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants . Int. J. Artif. Organs . 2006;29:395–401
  67. Jarlov JO , et al.   Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility . J. Hosp. Infect. . 1996;32:217–227
  68. Higaki S , et al.   Distribution and antimicrobial susceptibility of coagulase-negative staphylococci from skin lesions . J. Int. Med. Res. . 1999;27:191–195
  69. You YO , et al.   Staphylococcus lugdunensis — a potential pathogen in oral infection . Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. . 1999;88:297–302
  70. Ferreira RB , et al.   Coagulase-negative staphylococci: comparison of phenotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin . J. Clin. Microbiol. . 2003;41:3609–3614
  71. Hussain Z , et al.   Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci . J. Clin. Microbiol. . 2000;38:752–754
  72. Louie L , et al.   Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative staphylococci . J. Clin. Microbiol. . 2001;39:4149–4151
  73. CLSI  . Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI document M100-S15 . Wayne, PA: Clinical and Laboratory Standards Institute; 2005;
  74. Bourgeois I , et al.   Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci . Antimicrob. Agents Chemother. . 2007;51:740–743
  75. Dunne WM . Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci . Antimicrob. Agents Chemother. . 1990;34:390–393
  76. Rachid S , et al.   Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming . Staphylococcus epidermidis. Antimicrob. Agents Chemother. . 2000;44:3357–3363

 This article is based on Frank, K.L., J.L. del Pozo, and R. Patel. 2008. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin. Microbiol. Rev. 21:111–133.

PII: S0196-4399(08)00018-4

doi: 10.1016/j.clinmicnews.2008.03.004

Clinical Microbiology Newsletter
Volume 30, Issue 8 , Pages 55-62 , 15 April 2008

Article Tools

* Image Usage & Resolution